Literature DB >> 1519966

Myelodysplastic syndromes.

I M Hann1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1519966      PMCID： PMC1793828          DOI： 10.1136/adc.67.7.962

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  48 in total

1.  Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia.

Authors:  B D Nelkin; D Przepiorka; P J Burke; E D Thomas; S B Baylin
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

2.  Familial essential thrombocythemia.

Authors:  E Fernandez-Robles; C Vermylen; P Martiat; J Ninane; G Cornu
Journal:  Pediatr Hematol Oncol       Date:  1990       Impact factor: 1.969

3.  Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings.

Authors:  J M Brandwein; D E Horsman; A C Eaves; C J Eaves; B G Massing; L D Wadsworth; P C Rogers; D K Kalousek
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

4.  The occurrence of leukemia in patients with the Shwachman syndrome.

Authors:  W G Woods; J S Roloff; J N Lukens; W Krivit
Journal:  J Pediatr       Date:  1981-09       Impact factor: 4.406

5.  Neurofibromatosis and childhood leukemia.

Authors:  J L Bader; R W Miller
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

6.  RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.

Authors:  C Hirsch-Ginsberg; A C LeMaistre; H Kantarjian; M Talpaz; A Cork; E J Freireich; J M Trujillo; M S Lee; S A Stass
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

7.  Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia.

Authors:  T De Witte; P Muus; B De Pauw; C Haanen
Journal:  Cancer       Date:  1990-09-01       Impact factor: 6.860

8.  Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity.

Authors:  G Lambertenghi-Deliliers; A Orazi; R Luksch; C Annaloro; D Soligo
Journal:  Br J Haematol       Date:  1991-06       Impact factor: 6.998

Review 9.  The myelodysplastic syndromes: current approaches to therapy.

Authors:  B D Cheson
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

10.  Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis.

Authors:  Y Kaneko; N Maseki; M Sakurai; A Shibuya; T Shinohara; T Fujimoto; H Kanno; A Nishikawa
Journal:  Leukemia       Date:  1989-01       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.